Results 161 to 170 of about 114,683,953 (299)
Botulinum toxin A for the Treatment of Androgenetic Alopecia: A Review. [PDF]
Basch L, Carver C, Jacobs R.
europepmc +1 more source
This scoping review synthesizes evidence on atopic dermatitis (AD), psoriasis, and hidradenitis suppurativa in North American Indigenous peoples across 49 studies and 63 clinical trials. Findings reveal consistently high disease burden in AD, marked underrepresentation in trials and guidelines, and five evidence‐based recommendations to advance ...
Rachel Asiniwasis +17 more
wiley +1 more source
Cosmetic Dermatology in Pregnancy and Lactation: A Risk–Benefit Framework for Clinical Practice
Summary of the safety profile of common cosmetic dermatology interventions during pregnancy and lactation. ABSTRACT Cosmetic dermatologic products and procedures are increasingly utilized by women of reproductive age, including those who are pregnant or lactating.
Timea Kovacs +6 more
wiley +1 more source
Early Treatment of Post-Stroke Spasticity with Botulinum Toxin Type A: Myth or Reality? [PDF]
Picelli A +4 more
europepmc +1 more source
Cricopharyngeus (CP) muscle spasm can lead to severe dysphagia. Myotomy of the CP muscle was the treatment of choice. Recently, botulinum toxin type A (BtxA) has been used for CP spasm.
CHIU, MING-JANG;CHANG, YEUN-CHUNG;HSIAO, TZU-YU +1 more
core
Anterior Drooling Versus Posterior Drooling: A Comparative Analysis
ABSTRACT Aims To examine the patient population of a tertiary Interdisciplinary Saliva Control Clinic, describe management pathways and identify patients suitable for primary care. Methods Retrospective single‐centre cohort study in a tertiary hospital reviewing patients referred to the Saliva Control Clinic over a 5‐year period.
Kaitlin Duell +4 more
wiley +1 more source
Botulinum toxin type A injection in treatment of pediatric cyclic esotropia. [PDF]
Huang Y, Fu T, Zhang X, Li X, Wang C.
europepmc +1 more source
Botulinum Toxin Type A for Cervicogenic Headache: A Review of the Current Evidence. [PDF]
Vasconcelos Fonseca C +1 more
europepmc +1 more source
Spotlight on botulinum toxin and its potential in the treatment of stroke-related spasticity
Michelle Kaku, David M Simpson Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, USA Abstract: Poststroke spasticity affects up to one-half of stroke patients and has debilitating effects, contributing to diminished ...
Simpson DM, Kaku M
core
Abstract Muscle strength is a key predictor of physical functioning, yet the influence of patient and treatment factors on muscle properties in young people with cerebral palsy is not fully known. We explored whether medial gastrocnemius properties vary by age, ambulatory status and spasticity treatment (botulinum toxin or selective dorsal rhizotomy ...
Elizabeth R. Boyer +7 more
wiley +1 more source

